Steven Hyman serves as Executive at Cyclerion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Steven Hyman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 30, 2023 involved receiving (via award) 20,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 30, 2023 | CYCN | $0 | Award | 20,000 | $N/A | Discretionary |
Steven Hyman currently holds 20,000 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Hyman has been a net neutral trader of CYCN stock. They have purchased $0 and sold $0 worth of shares.
Steven Hyman's most recent insider trade was on Nov 30, 2023, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted